Atherosclerosis

Atherosclerosis is a chronic, progressive degenerative disease of the arterial wall characterized by the accumulation of lipids, inflammatory cells, fibrous tissue, and calcium within the intima and media of large- and medium-sized elastic and muscular arteries. In avian species, particularly psittaciformes (parrots, cockatoos, macaws) and some raptors, atherosclerosis is a leading cause of morbidity and mortality, often presenting as sudden death or chronic cardiovascular and neurological signs. The disease is analogous to human atherosclerosis but exhibits species-specific differences in lipid metabolism, arterial anatomy, and clinical presentation. In birds, the aorta, brachiocephalic arteries, and coronary arteries are most commonly affected. The condition is often subclinical until advanced, and diagnosis requires a high index of suspicion, advanced imaging, and post-mortem examination. Atherosclerosis is classified histologically into stages: fatty streaks, fibrofatty plaques, and complicated lesions with hemorrhage, thrombosis, or calcification. In psittacines, the disease is strongly associated with high-fat, high-cholesterol diets, lack of exercise, obesity, and genetic predisposition, particularly in Amazon parrots, African grey parrots, and cockatiels.

The etiology of atherosclerosis in birds is multifactorial, involving a complex interplay of genetic, nutritional, metabolic, and environmental factors. Primary nutritional causes include diets excessively high in fat, cholesterol, and simple carbohydrates, such as seed-based diets (sunflower seeds, peanuts) and human table foods. These diets lead to hyperlipidemia, particularly hypercholesterolemia and elevated low-density lipoproteins (LDL), which are key drivers of plaque formation. Metabolic factors include obesity, insulin resistance, and hypothyroidism, which are common in captive psittacines. Genetic predisposition is significant, with certain species and individual birds showing higher susceptibility. Environmental factors such as lack of exercise, chronic stress, and indoor confinement contribute to the disease. Secondary causes include infectious agents (e.g., Chlamydia psittaci, which can cause vasculitis), hypertension, and chronic inflammation. In raptors, atherosclerosis is often associated with high-fat diets of whole prey (e.g., quail, mice) and lack of exercise. The cellular mechanism involves endothelial injury, lipid oxidation, and inflammatory cell infiltration, leading to smooth muscle cell proliferation and extracellular matrix deposition.

Atherosclerosis is one of the most common diseases of captive psittacines, with prevalence rates ranging from 10% to 90% depending on species, age, and diet. It is particularly prevalent in Amazon parrots (Amazona spp.), African grey parrots (Psittacus erithacus), cockatiels (Nymphicus hollandicus), and macaws (Ara spp.). In a retrospective study of psittacine necropsies, atherosclerosis was identified in 46% of Amazon parrots and 38% of African grey parrots. The disease is more common in older birds (>5 years), with a peak incidence in middle-aged to senior birds (10-20 years). There is no significant sex predilection, but females may be slightly more affected due to reproductive-associated lipid metabolism. Captive birds are at higher risk than wild birds due to diet and lifestyle. In raptors, atherosclerosis is less common but has been reported in captive birds of prey, particularly those fed high-fat diets. The disease is rare in poultry and waterfowl. Risk factors include obesity, high-fat diet, lack of exercise, and genetic predisposition. In a study of 100 psittacines, birds fed a seed-based diet had a 3.5-fold higher risk of developing atherosclerosis compared to those fed a pelleted diet.

The pathophysiology of atherosclerosis in birds is similar to that in humans. It begins with endothelial dysfunction, often triggered by chronic hyperlipidemia, hypertension, or inflammation. The endothelium becomes more permeable to lipoproteins, particularly LDL, which accumulate in the intima. These lipoproteins undergo oxidation, stimulating the expression of adhesion molecules and chemokines that recruit monocytes and T-lymphocytes. Monocytes differentiate into macrophages, which engulf oxidized LDL to form foam cells. Foam cells accumulate, forming fatty streaks. Over time, smooth muscle cells migrate from the media to the intima, proliferate, and produce collagen and proteoglycans, forming a fibrous cap over the lipid core. This creates a fibrofatty plaque. As the plaque progresses, it can become calcified, ulcerated, or rupture, leading to thrombosis and vascular occlusion. In birds, the disease often affects the brachiocephalic arteries, leading to cerebral ischemia and neurological signs. Coronary artery involvement can cause myocardial infarction and sudden death. The disease also leads to arterial stiffness, increasing cardiac workload and potentially causing congestive heart failure. In psittacines, the disease is often associated with hepatic lipidosis and hypercholesterolemia, which exacerbate the condition. The metabolic syndrome in birds, characterized by obesity, insulin resistance, and dyslipidemia, is a key driver of atherosclerosis.

Predisposing factors for atherosclerosis in birds include intrinsic and extrinsic factors. Intrinsic factors include species-specific genetic susceptibility, age (older birds are more prone), sex (females may be at higher risk due to reproductive hormones), and individual metabolic variations. Certain species, such as Amazon parrots, African grey parrots, and cockatiels, have a higher genetic predisposition. Extrinsic factors are primarily dietary: high-fat, high-cholesterol, seed-based diets, and overfeeding of human foods. Lack of exercise and obesity are major contributors. Environmental factors such as chronic stress, overcrowding, and lack of mental stimulation can also increase risk. Inadequate husbandry, including poor hygiene and exposure to toxins (e.g., cigarette smoke, air pollution), may contribute. Concurrent diseases such as hypothyroidism, diabetes mellitus, and chronic inflammation (e.g., chlamydiosis) can accelerate atherosclerosis. In raptors, feeding high-fat prey (e.g., quail) and lack of flight exercise are significant risk factors. Additionally, genetic selection in breeding programs may inadvertently increase susceptibility.

Clinical signs of atherosclerosis in birds are often non-specific and may be absent until the disease is advanced. Common signs include exercise intolerance, lethargy, weakness, and dyspnea. Birds may show neurological signs such as ataxia, seizures, syncope, or sudden death due to cerebral ischemia or cardiac arrhythmias. In psittacines, signs of heart failure may include abdominal distension, ascites, and respiratory distress. Some birds may present with lameness or paralysis due to thromboembolism. On physical examination, birds may have a palpable cranial coelomic mass (due to cardiomegaly), muffled heart sounds, or arrhythmias. Chronic cases may show poor feather condition, weight loss, or obesity. In raptors, signs may include sudden death during training or flight. It is important to note that many birds with atherosclerosis are asymptomatic, and the disease is often an incidental finding at necropsy. Therefore, a high index of suspicion is needed in high-risk species and older birds.

Differential diagnoses for atherosclerosis in birds include: 1) Congestive heart failure (CHF) due to other causes such as valvular disease, cardiomyopathy, or myocarditis; 2) Hepatic lipidosis, which can cause similar non-specific signs and is often concurrent; 3) Respiratory diseases such as aspergillosis, pneumonia, or air sacculitis, which can cause dyspnea; 4) Neurological conditions such as lead toxicosis, zinc toxicosis, or viral encephalitis (e.g., bornavirus), which can cause ataxia and seizures; 5) Neoplasia, such as lymphoma or adenocarcinoma, which can cause coelomic masses and lethargy; 6) Chlamydiosis, which can cause respiratory and hepatic signs; 7) Hypothyroidism, which can cause obesity and lethargy; 8) Chronic egg laying or reproductive disorders in females, which can cause coelomic distension and metabolic stress. Definitive diagnosis requires imaging (radiographs, echocardiography, CT) and blood work (cholesterol, triglycerides, cardiac biomarkers).

The diagnostic algorithm for atherosclerosis in birds begins with a thorough history and physical examination, with special attention to species, age, diet, and clinical signs. If atherosclerosis is suspected, the following steps are recommended: 1) Minimally invasive diagnostics: Complete blood count (CBC) and serum biochemistry panel, including lipid profile (cholesterol, triglycerides, HDL, LDL), liver enzymes (AST, bile acids), and cardiac biomarkers (e.g., troponin I, CK). 2) Whole-body radiographs (ventrodorsal and lateral views) to assess cardiac size, shape, and vascular calcification. 3) Echocardiography (ultrasonography) to evaluate cardiac function, chamber dimensions, and arterial wall thickness. 4) Advanced imaging: Computed tomography (CT) or magnetic resonance imaging (MRI) for detailed assessment of vascular calcification and plaque burden. 5) Blood pressure measurement (Doppler) to assess hypertension. 6) Endoscopy (if indicated) to visualize the heart and major vessels. 7) If the bird is stable, a trial of dietary modification and exercise may be initiated. 8) Definitive diagnosis often requires post-mortem examination, but antemortem diagnosis is possible with advanced imaging. The diagnostic approach should be tailored to the individual bird's condition and owner's wishes.

Laboratory findings in birds with atherosclerosis often include hypercholesterolemia (elevated total cholesterol, LDL, and triglycerides), which is a key indicator. However, normal cholesterol levels do not rule out the disease. Hematology may show non-specific changes such as leukocytosis or heterophilia due to inflammation. Serum biochemistry may reveal elevated liver enzymes (AST, bile acids) due to concurrent hepatic lipidosis. Cardiac biomarkers such as troponin I and CK-MB may be elevated in cases of myocardial damage. In psittacines, hyperuricemia may be present if renal function is compromised. Fecal analysis is usually unremarkable. Serology for infectious agents (e.g., Chlamydia) may be performed to rule out concurrent infections. In advanced cases, blood gas analysis may show hypoxemia. It is important to note that laboratory findings are not specific, and imaging is essential for diagnosis.

Imaging plays a crucial role in the antemortem diagnosis of atherosclerosis in birds. Radiography (ventrodorsal and lateral views) may reveal cardiomegaly, particularly an enlarged cardiac silhouette, and calcification of the aorta or brachiocephalic arteries, which appears as linear radiopacities. However, radiography is insensitive for early disease. Echocardiography (ultrasonography) is more sensitive and can assess cardiac chamber dimensions, wall thickness, and contractility. It can also visualize the proximal aorta and brachiocephalic arteries for atherosclerotic plaques, which appear as hyperechoic intimal thickening. Doppler ultrasound can measure blood flow velocities and detect stenosis. Computed tomography (CT) is the gold standard for antemortem diagnosis, providing high-resolution images of vascular calcification and plaque burden. CT angiography can further delineate luminal narrowing. Magnetic resonance imaging (MRI) is less commonly used but can assess plaque composition. Endoscopy, particularly coelioscopy, can visualize the heart and major vessels directly, but is invasive. Imaging findings should be correlated with clinical signs and laboratory results.

Cytology and histopathology are essential for definitive diagnosis of atherosclerosis, but are typically performed post-mortem. On gross necropsy, affected arteries are thickened, firm, and may show yellowish-white plaques or calcification. Histologically, the lesions are characterized by intimal thickening with lipid-laden macrophages (foam cells), smooth muscle cell proliferation, collagen deposition, and variable degrees of calcification. Advanced lesions may show necrosis, hemorrhage, or thrombosis. In birds, the lesions are often more fibrotic and calcified than in mammals. Histochemical stains such as Oil Red O can highlight lipids, and von Kossa stain can demonstrate calcium. Immunohistochemistry for smooth muscle actin and macrophages can help characterize the plaque. Cytology of fine-needle aspirates of arterial lesions is rarely performed antemortem but may show lipid-laden macrophages. In research settings, histopathology is used to grade the severity of atherosclerosis.

Treatment of atherosclerosis in birds focuses on managing clinical signs, slowing disease progression, and addressing underlying risk factors. Emergency stabilization may be required for birds with heart failure or neurological signs, including oxygen therapy, diuretics (e.g., furosemide 1-4 mg/kg IM/IV q8-12h), and vasodilators (e.g., enalapril 0.5-1 mg/kg PO q12-24h). Long-term management includes dietary modification to a low-fat, low-cholesterol, high-fiber pelleted diet, with gradual transition from seed-based diets. Weight management and increased exercise are crucial. Pharmacological interventions may include lipid-lowering agents such as statins (e.g., atorvastatin 1-2 mg/kg PO q24h) or fibrates (e.g., gemfibrozil 10-20 mg/kg PO q12h), though these are not well-studied in birds. Omega-3 fatty acid supplements (e.g., fish oil 100-300 mg/kg PO q24h) may help reduce inflammation. Antioxidants such as vitamin E (10-30 IU/kg PO q24h) may be beneficial. In cases of hypothyroidism, levothyroxine (0.02-0.05 mg/kg PO q12h) may be indicated. Regular monitoring of lipid profiles and imaging is essential. Surgical intervention is rarely indicated, but in cases of thromboembolism, anticoagulant therapy (e.g., clopidogrel 1-2 mg/kg PO q24h) may be considered. Environmental enrichment and stress reduction are important adjuncts.

The prognosis for birds with atherosclerosis is guarded to poor, depending on the severity and presence of complications. Birds with subclinical disease may live for years with appropriate management, but the disease is progressive. Birds presenting with acute signs such as syncope or heart failure have a poor prognosis, with a high risk of sudden death. The presence of severe calcification, thrombosis, or myocardial infarction is associated with a grave prognosis. Response to treatment is variable; some birds show improvement in clinical signs with dietary modification and medication, but the underlying vascular damage is irreversible. Negative prognostic indicators include advanced age, severe hypercholesterolemia, concurrent hepatic lipidosis, and evidence of cardiac dysfunction on echocardiography. Regular monitoring and aggressive risk factor management may slow progression and improve quality of life, but cure is not possible.

Follow-up for birds with atherosclerosis should be structured and regular. Initially, re-evaluation should occur every 2-4 weeks until clinical signs are stable. At each visit, body weight, body condition score, and lipid profile (cholesterol, triglycerides) should be assessed. Blood pressure should be measured if hypertension is present. Echocardiography or CT should be repeated every 6-12 months to monitor disease progression. Dietary compliance should be reviewed, and adjustments made as needed. Owners should be educated on the importance of exercise and environmental enrichment. In cases of heart failure, medications may need adjustment based on clinical response. Long-term monitoring is essential to detect complications such as thromboembolism or heart failure. A multidisciplinary approach involving the owner and veterinarian is key to successful management.

Clinical pearls: 1) In psittacines, a high index of suspicion for atherosclerosis is warranted in older Amazon parrots and African grey parrots, especially those with a history of seed-based diets. 2) Radiographic evidence of vascular calcification is a late finding; echocardiography or CT is needed for early diagnosis. 3) Blood pressure measurement is important, as hypertension is common in affected birds. 4) Dietary modification is the cornerstone of management; gradual transition to a pelleted diet is essential to avoid stress. 5) Omega-3 fatty acids may help reduce inflammation and improve lipid profiles. Pitfalls: 1) Do not rely solely on cholesterol levels; normal cholesterol does not rule out atherosclerosis. 2) Avoid the use of corticosteroids, as they can exacerbate hyperlipidemia and immunosuppression. 3) Be cautious with the use of statins, as they may cause hepatotoxicity in birds; monitor liver enzymes. 4) Do not overlook concurrent diseases such as hypothyroidism or chlamydiosis, which may require specific treatment. 5) Sudden death is common; owners should be warned of this risk.

Current drug protocols for atherosclerosis in birds are based on extrapolation from human and mammalian medicine, as there are few avian-specific studies. Common medications include: 1) Furosemide (diuretic) for heart failure: 1-4 mg/kg IM/IV q8-12h, then 0.5-2 mg/kg PO q12-24h. 2) Enalapril (ACE inhibitor) for hypertension and heart failure: 0.5-1 mg/kg PO q12-24h. 3) Atorvastatin (statin) for hypercholesterolemia: 1-2 mg/kg PO q24h. 4) Gemfibrozil (fibrate) for hypertriglyceridemia: 10-20 mg/kg PO q12h. 5) Omega-3 fatty acids (fish oil) as anti-inflammatory: 100-300 mg/kg PO q24h. 6) Vitamin E as antioxidant: 10-30 IU/kg PO q24h. 7) Levothyroxine for hypothyroidism: 0.02-0.05 mg/kg PO q12h. 8) Clopidogrel (antiplatelet) for thromboembolism prevention: 1-2 mg/kg PO q24h. 9) Aspirin (antiplatelet) at 5-10 mg/kg PO q24h (use with caution due to GI side effects). 10) Fluid therapy for stabilization: Lactated Ringer's solution or Normosol-R at 10-20 mL/kg SC/IV q24h, adjusted based on hydration status. All dosages should be adjusted based on species, individual response, and monitoring. It is crucial to monitor liver and kidney function during therapy.

Evidence-based literature on avian atherosclerosis is limited but growing. Key studies include: 1) A retrospective study by Beaufrère et al. (2013) in Journal of Avian Medicine and Surgery, which found a high prevalence of atherosclerosis in psittacines and identified risk factors such as age, diet, and species. 2) A study by Bavelaar and Beynen (2004) on the effect of diet on plasma cholesterol in African grey parrots, demonstrating that a pelleted diet significantly reduced cholesterol levels compared to a seed-based diet. 3) A study by Krautwald-Junghanns et al. (2014) using CT to diagnose atherosclerosis in psittacines, showing that CT is a sensitive diagnostic tool. 4) A consensus statement by the Association of Avian Veterinarians (AAV) on the management of atherosclerosis, recommending dietary modification, exercise, and monitoring of lipid profiles. 5) A study by Shrubsole-Cockwill et al. (2008) on the use of omega-3 fatty acids in psittacines, showing improvement in lipid profiles. 6) A review by Beaufrère (2018) in Veterinary Clinics of North America: Exotic Animal Practice, summarizing current knowledge and therapeutic options. These studies highlight the importance of preventive measures and the need for further research on pharmacological interventions.